The Confluence of Diagnostics and Therapeutics
February 24, 2012
Location
Indianapolis- Barnes & Thornburg LLP
11 South Meridian Street, Indianapolis, IN*Parking is available at the Denison Parking Garage located on Meridian Street, just south of Barnes & Thornburg. The cost is around $14 to park and you pay in the lobby before leaving with debit, credit or cash. Parking is also available at the Circle Centre Mall just a couple of blocks from Barnes & Thornburg at a lower rate.
- Primary Sponsors
- Overview
As the human genome has been mapped and understanding of genetic markers increases, opportunities to tailor treatment for specific patients and groups of patients should grow exponentially. Turning this vision into reality will require coordinated efforts in both the diagnostic and pharmaceutical arenas However, the question can be asked as to which is more valuable – the test that identifies a patient’s condition or the treatment that alleviates or eliminates the condition. This conference looks into how life sciences firms are partnering, merging, acquiring and/or competing in response and will delve into the discussion of value in the healthcare system and how it could/should be divided.
- Agenda
8:00 – 9:00 am Registration and Breakfast 9:00 am – 9:15 am Welcome and Introduction of Opening Keynote Speaker Rob Brown, Senior Vice President-Marketing and Chief Marketing Officer, Eli Lilly & Company 9:15 am – 10:15 am Keynote Presentation: The Global Transformation of Healthcare Brian Williams, Director, Global Healthcare, PwC - (presentation) 10:15 am – 10:30 am Break and Networking 10:30 am – 12:00 pm Panel Presentation: Threading the Regulatory Needle Panel Moderator: Dr. Tracy Bush, Director, Companion Diagnostics Regulatory Affairs, Roche Diagnostics Christine Gathers, Senior Director, Global Regulatory Affairs Diagnostic, Eli Lilly & Company- (presentation) Scott Thiel, Senior Regulatory Consultant, The Anson Group, LLC- (presentation) Chris Henza, Regulatory Affairs Specialist, Regulatory Compliance Associates Inc.- (presentation) David Kern, Senior Director, Myraqa Inc.- (presentation) 12:00 pm – 12:30 pm Lunch/Networking 12:30 pm – 1:30 pm Keynote (presentation): Fitting the Treatment to the Patient-Roche Personalized Healthcare Introduction: David Shenberger, Commissioning Agents, Inc.
Mark Rutledge, Director of Marketing, Molecular Diagnostics, Roche Diagnostics (presentation)
1:30 – 3:00 pm Panel Presentation: Partnering for Success Moderator: Scott Simmonds, Partner, Intellectual Property Department, Barnes & Thornburg LLP Nicolaos (Niko) Drivas, Director of Business Development and Business Licensing, Abbott Molecular Mollie Roth, J.D., Chief Operating Officer, Diaceutics Blake Cooper, Attorney, Business Department, Barnes & Thornburg LLP Michael Stocum, President and Founder, Personalized Medicine Partners 3:00 – 3:15 pm Concluding Comments George M. Telthorst, Director, Center for the Business of Life Sciences, IU Kelley School of Business
